In the ever-evolving world of pharmaceuticals, Olon continues to push the boundaries of what’s possible. We’re excited to introduce a…
It has been an outstanding CPHI for Olon, it achieved an incredible success at 2023 Global Generic and Biosimilar Awards…
On the occasion of CPhI Worldwide 2023 (Barcelona, 24 – 26 Oct), the most important international event of the chemical-pharmaceutical…
The Group announced the completion of works and the finalisation of a new production area at the Settimo site, with…
Milan, Italy, October 5, 2023 – Olon is proud to publish its annual Corporate Sustainability Report, which details the global…
In the last decade, high-resolution mass spectrometry (HRMS) has emerged as a powerful technique in many fields of biological studies,…
Olon announces a new investment to further increase the production capacity, in one of the facilities dedicated to biotechnological production.…
Milan, Italy – XXX May 2023 – OLON Group, a global leader in the development and production of ac-tive pharmaceutical…
Olon, global leader in the development and production of active pharmaceutical ingredients (APIs) for CDMO and generic markets, integrating chemical…